益丰药房: 益丰药房关于2025年半年度主要经营数据的公告

董事会 | 48.53% 中药 | 1,149,179,170.30 | 591,516,245.07 | | -1.34% | -0.94% | -0.21% | | | --- | --- | --- | --- | --- | --- | --- | --- | | 非药品 51.78% | 1,319,793,544.62 | 636,351,168.89 | | -2.44% | -3.80% | 0.69% | | | 合计 38.80% | 11,367,910,203.96 | 6,957,376,796.08 | | -0.24% | -1.21% | 0.60% | | | 主营业务分地区情况 | | | | | | | | | 分地区 毛利率 | | | | | | | | | 营业收入 | | 营业成本 | | | 年同期增减 | 年同期增减 | 年同期增 | | 减 | | | | | | | | | 中南 42.26% | 5,344,295,335.09 | 3,085,886,663.37 | | 0.45% | -1.13% | 0.92% | | | 36.27% 华东 | ...